Wellthy Therapeutics is a Cardiometabolic InsurTech company that uses a Human – Artificial Intelligence (AI) hybrid along with proven behaviour change models to improve policyholder and patient health outcomes in Asia. It develops and deploys InsurTech solutions that work synergistically with insurers to improve health, quality of life, and enable better outcomes. Live now with a few health and life insurers in India, its digital therapeutic solution has shown proven ability to significantly reduce risk. One such pilot with South Asia’s largest private health insurer is already complete, with the results being presented at the world’s largest diabetes conference later this year.
Wellthy Therapeutics develops new policies that can go to market across Asia for prevention and reduction of cardiovascular and chronic disease risk, to engage and reduce the risk of the in-force book, and to enable ‘risky’ rejected customers to come back into the insurable risk pool.
It’s first digital therapeutic for type II diabetes is already prescribed by doctors to patients in India, and its second digital therapeutic in chronic kidney disease is leading South Asia’s largest dialysis prevention program. Going forward, Wellthy Therapeutics will be working to cover more diseases across the cardio metabolic spectrum, while launching in select Asian markets with our insurance and hospital system partners.
Wellthy has a proven track record of clinical efficacy, with outcomes data presented at conferences by the American Diabetes Association (ADA), International Diabetes Federation (IDF), American Association for Clinical Endocrinology (AACE), Advanced Technologies & Treatments in Diabetes (ATTD) and the Research Society for Study of Diabetes in India (RSSDI).
Wellthy has raised a seed round of $2M in 2018 from from marquee investors who brought expertise in both healthcare and technology. GrowX ventures was the first investor to come on board. Other investors include strategists like Dr. Ranjan Pai, Manipal Group, Beenext Ventures, Currae Healthcare and others.